These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7528446)

  • 1. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF
    Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reduction in hematotoxicity of chemotherapy using reinfusion of hematopoietic stem cells].
    van Hoef ME
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):240-4. PubMed ID: 8094541
    [No Abstract]   [Full Text] [Related]  

  • 6. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood stem cells: in vivo biology and therapeutic potential.
    Scheding S; Brugger W; Mertelsmann R; Kanz L
    Stem Cells; 1994; 12 Suppl 1():203-10; discussion 211. PubMed ID: 7535146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo manipulations of CD34+ peripheral blood progenitor cells.
    Brugger W; Scheding S; Vogel W; Bock T; Bühring HJ; Ziegler B; Kanz L
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S5-7. PubMed ID: 8899158
    [No Abstract]   [Full Text] [Related]  

  • 9. CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
    Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF
    Prog Clin Biol Res; 1994; 389():303-8. PubMed ID: 7535435
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy.
    Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M
    Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy: therapeutic potential in the age of growth factor support.
    Ariad S; Bezwoda WR
    Isr J Med Sci; 1992 Jun; 28(6):377-85. PubMed ID: 1607279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in various malignancies.
    Efremidis AP; Koumakis G; Filis J; Moraki M; Vassilomanolakis M; Barbounis V; Hatzichristou H; Papanastasiou K; Stamatellou M
    Bone Marrow Transplant; 1996 Apr; 17(4):673-4. PubMed ID: 8722374
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A; Begley CG; Juttner CA; Szer J; To LB; Maher D; McGrath KM; Morstyn G; Fox RM; Sheridan WP
    Bone Marrow Transplant; 1993; 11 Suppl 2():23-9. PubMed ID: 8334435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
    Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
    Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
    [No Abstract]   [Full Text] [Related]  

  • 16. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
    Akabutu JJ; Chan JR
    Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
    Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
    Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.